Literature DB >> 17031717

Histopathological workup of an Amplatzer atrial septal defect occluder after surgical removal.

Matthias Sigler1, Christian Jux, Peter Ewert.   

Abstract

We present results of the histopathological work-up of an atrial septal defect occluder that was explanted 15 months after interventional implantation due to a significant residual shunt. Complete endothelialization of the surface and a mild inflammatory reaction was demonstrated.

Entities:  

Mesh：

Year:  2006        PMID： 17031717     DOI： 10.1007/s00246-006-1413-1

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN： 0172-0643            Impact factor:   1.655


  4 in total

1.  Transvenous closure of secundum atrial septal defects: preliminary results with a new self-expanding nitinol prosthesis in a swine model.

Authors:  M J Sharafuddin; X Gu; J L Titus; M Urness; J J Cervera-Ceballos; K Amplatz
Journal:  Circulation       Date:  1997-04-15       Impact factor: 29.690

2.  Transcatheter closure as standard treatment for most interatrial defects: experience in 200 patients treated with the Amplatzer Septal Occluder.

Authors:  F Berger; P Ewert; P G Björnstad; I Dähnert; G Krings; I Brilla-Austenat; M Vogel; P E Lange
Journal:  Cardiol Young       Date:  1999-09       Impact factor: 1.093

Review 3.  Biocompatibility screening in cardiovascular implants.

Authors:  M Sigler; T Paul; R G Grabitz
Journal:  Z Kardiol       Date:  2005-06

4.  Long-term outcome of transcatheter secundum-type atrial septal defect closure using Amplatzer septal occluders.

Authors:  Jozef Masura; Pavol Gavora; Tomaz Podnar
Journal:  J Am Coll Cardiol       Date:  2005-02-15       Impact factor: 24.094
  4 in total
  7 in total

1.  Neointima-inducing inflow cannula with titanium mesh for left ventricular assist device.

Authors:  Yukiko Yamada; Tomohiro Nishinaka; Toshihide Mizuno; Yoshiyuki Taenaka; Eisuke Tatsumi; Kenji Yamazaki
Journal:  J Artif Organs       Date:  2011-07-07       Impact factor: 1.731

2.  Secondary residual shunt after atrial septal defect closure with an amplatzer occluder: surgical removal and evaluation of device biocompatibility after 7 years.

Authors:  Weihua Zhu; Henning Neubauer
Journal:  Pediatr Cardiol       Date:  2010-08-01       Impact factor: 1.655

3.  Endocarditis and Incomplete Endothelialization 12 Years after Amplatzer Septal Occluder Deployment.

Authors:  Allan K Nguyen; Brian A Palafox; Joanne P Starr; Richard N Gates; Farbouch Berdjis
Journal:  Tex Heart Inst J       Date:  2016-06-01

4.  Angioscopic Evaluation of Atrial Septal Defect Closure Device Neo-Endothelialization.

Authors:  Yasuhiro Tanabe; Tomomi Suzuki; Shingo Kuwata; Masaki Izumo; Hiromasa Kawaguchi; Shun Ogoda; Nozomi Kotoku; Yukio Sato; Haruka Nishikawa; Toshiki Kaihara; Masashi Koga; Takanobu Mitarai; Kazuaki Okuyama; Ryo Kamijima; Yuki Ishibashi; Kihei Yoneyama; Takumi Higuma; Tomoo Harada; Yoshihiro J Akashi
Journal:  J Am Heart Assoc       Date:  2021-09-17       Impact factor: 5.501

5.  A Rare Ultra-Long-Term Complication of Occluder Recanalization Due to Spontaneous Perforation of Polyvinyl Alcohol Membrane of Atrial Septal Defect Occluder: A Case Report and Review of the Literature.

Authors:  Kun Xiang; Huanwei Zhuang; Qin Wu; Mi Tang; Jinfu Yang; Chengming Fan
Journal:  Front Cardiovasc Med       Date:  2022-07-22

6.  Assessment of Device Neoendothelialization With Cardiac Computed Tomography Angiography After Transcatheter Closure of Atrial Septal Defect.

Authors:  Ah Young Kim; Wongi Woo; Beom Jin Lim; Jo Won Jung; Jae Young Choi; Young Jin Kim
Journal:  Circ Cardiovasc Imaging       Date:  2022-07-19       Impact factor: 8.589

7.  A comparison of the in vivo neoendothelialization and wound healing processes of three atrial septal defect occluders used during childhood in a nonrandomized prospective trial.

Authors:  Derya Aydın Şahin; Osman Başpınar; Ayşe Sülü; Tekin Karslıgil; Seval Kul
Journal:  Anatol J Cardiol       Date:  2017-07-25       Impact factor: 1.596
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.